Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001345099-25-000021
Filing Date
2025-03-13
Accepted
2025-03-13 06:25:14
Documents
26
Period of Report
2025-03-13

Document Format Files

Seq Description Document Type Size
1 6-K a2025-03x13isctpresentatio.htm 6-K 22643
2 EX-99.1 exhibit991.htm EX-99.1 20261
3 EX-99.2 exhibit992.htm EX-99.2 5235
4 exhibit991001.jpg GRAPHIC 70668
5 exhibit991002.jpg GRAPHIC 158354
6 exhibit991003.jpg GRAPHIC 83016
7 exhibit991004.jpg GRAPHIC 117902
8 exhibit991005.jpg GRAPHIC 108171
9 exhibit991006.jpg GRAPHIC 112826
10 exhibit991007.jpg GRAPHIC 82904
11 exhibit991008.jpg GRAPHIC 97568
12 exhibit991009.jpg GRAPHIC 158509
13 exhibit991010.jpg GRAPHIC 90793
14 exhibit991011.jpg GRAPHIC 96429
15 exhibit991012.jpg GRAPHIC 80998
16 exhibit991013.jpg GRAPHIC 142490
17 exhibit991014.jpg GRAPHIC 109624
18 exhibit991015.jpg GRAPHIC 127764
19 exhibit991016.jpg GRAPHIC 109272
20 exhibit991017.jpg GRAPHIC 108311
21 exhibit991018.jpg GRAPHIC 140755
22 exhibit991019.jpg GRAPHIC 102782
23 exhibit991020.jpg GRAPHIC 38027
24 exhibit992001.jpg GRAPHIC 138381
25 exhibit992002.jpg GRAPHIC 119495
26 exhibit992003.jpg GRAPHIC 61910
  Complete submission text file 0001345099-25-000021.txt   3435006
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 25733744
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)